Approval · Notice of Compliance 17315 · 2015
ONSIOR: Notice of Compliance 17315
Issued September 24, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17315
- Date
- September 24, 2015
- Company
- Novartis Animal Health Canada Inc.Mississauga, Ontario, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New species: cats
- Therapeutic class
- Non-steroidal anti--inflammatory
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ONSIOR | 02374382 | Marketed |
Medicinal ingredients
- ROBENACOXIB 20 MG per ML